The Food and Drug Administration on Tuesday named a longtime regulator of cancer medicines to lead the agency's drug center, ...

A 26-year FDA scientist and administrator, Pazdur has headed the agency's Oncology Center of Excellence since its creation in ...

The FDA on Nov. 11 appointed Richard Pazdur, MD, as the new director of the Center for Drug Evaluation and Research.Pazdur ...

Both The U.S. Department of Health and Human Services (HHS) and the FDA announced the appointment of Richard Pazdur, M.D., as director of the Center for Drug Evaluation and Research (CDER). 1 ...

Ethicist Art Caplan discusses FDA layoffs and their impact on protection of human research subjects in clinical trials.

As 2026 approaches, now is the time to reflect on the victories from the year and the lessons to be taken moving forward.

An investigation by FDA scientists revealed numerous data inaccuracies in reports that data vendor IQVIA provided to the agency, including data on opioid drug products, the agency announced May 16.

FDA sign & Bldg 21 at Entrance PHOTO COURTESY OF COMMONS.WIKIMEDIA.ORG Washington (AP) — Hormone based drugs used to treat ...

Secretary of Health and Human Services Robert F. Kennedy, Jr., recently announced that the U.S. Food and Drug Administration will launch a review of the safety of the abortion pill, mifepristone.

The U.S. Food and Drug Administration (FDA) is tightening restrictions on a gene therapy used to treat Duchenne muscular ...